Thermal spread with Voyant 5 mm Fusion versus LigaSure 5 mm Blunt Tip Devices

Abstract

Thermal spread is an unavoidable side-effect of electrocautery, however limiting it is important for minimizing damage to surrounding tissues. LigaSure 5 mm Blunt Tip has been in use since 2009 while Voyant 5 mm Fusion has only been FDA approved since 2018. Our hospital, a rural academic tertiary care center, recently moved to purchasing Voyant because of cost concerns. We aimed to compare the thermal spread of the two tools on raw pork meat at two different cut depths and on both right and left sides. The LigaSure device had significantly less thermal spread than Voyant across all measurements. Based on our data, the LigaSure device should be chosen for use despite the increased cost.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Guthrie Robert Packer Hospital Institutional Review Board gave ethical approval for this retrospective chart review.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data are available upon reasonable request to the author.

留言 (0)

沒有登入
gif